Long-Term Rivaroxaban for the Treatment of Acute Venous Thromboembolism in Patients with Active Cancer in a Prospective Multicenter Trial: KVTE13-01

被引：0
|
作者：
Yhim, Ho-Young
Choi, Won-Il
Kim, Sung-Hyun
Nam, Seung-Hyun
Kim, Kyoung Ha
Mun, Yeung-Chul
Hwang, Hun-Gyu
Oh, Doyeun
Lee, Keun-Wook
Song, Eun-Kee
Kwon, Yong Shik
Bang, Soo-Mee
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3711
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Patient-reported treatment satisfaction with Rivaroxaban in cancer patients with acute venous thromboembolism - Results from the CONKO-011 trial
    Sinn, M.
    Juehling, A.
    Hellmann, M.
    Omar, M.
    Suedhoff, T.
    Stahl, M.
    Krziwanie, A.
    Schlenska-Lange, A.
    Rutzner, S.
    Heinz, J.
    Ettrich, T.
    Trappe, R.
    Striefler, J.
    Pelzer, U.
    Wernecke, K. -D
    Riess, H.
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 276 - 277
  • [32] Clot-regression effects of rivaroxaban in venous thromboembolism treatment in cancer patients-a prospective interventional study
    Takai, Shigeki
    Nakanishi, Naohiko
    Yokota, Isao
    Imai, Kojiro
    Yamada, Ayumu
    Kawasaki, Takanori
    Kasahara, Takeru
    Okada, Takashi
    Sawada, Takahisa
    Matoba, Satoaki
    SCIENTIFIC REPORTS, 2022, 12 (01):
  • [33] The short- and long-term risk of venous thromboembolism in patients with acute spinal cord injury A prospective cohort study
    Pierfranceschi, Matteo Giorgi
    Donadini, Marco P.
    Dentali, Francesco
    Ageno, Walter
    Marazzi, Marina
    Bocchi, Romeo
    Imberti, Davide
    THROMBOSIS AND HAEMOSTASIS, 2013, 109 (01) : 34 - 38
  • [34] Oral Rivaroxaban for the Treatment of Symptomatic Venous Thromboembolism in 400 Patients With Active Cancer: A Single-Center Experience
    Pignataro, Bruno Soriano
    Nishinari, Kenji
    Cavalcante, Rafael Noronha
    Centofanti, Guilherme
    Yazbek, Guilherme
    Krutman, Mariana
    Zotelle Bomfim, Guilherme Andre
    Imagawa Fonseca, Igor Yoshio
    Teivelis, Marcelo Passos
    Wolosker, Nelson
    Sanches, Solange Moraes
    Ramacciotti, Eduardo
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2017, 23 (07) : 883 - 887
  • [35] Patient-reported outcomes associated with switching to rivaroxaban for the treatment of venous thromboembolism (VTE) in patients with active cancer
    Cohen, A. T.
    Maraveyas, A.
    Beyer-Westendorf, J.
    Lee, A. Y. Y.
    Mantovani, L. G.
    Folkerts, K.
    Bach, M.
    De Sanctis, Y.
    Abdelgawad, K.
    ANNALS OF ONCOLOGY, 2019, 30
  • [36] A Randomized Trial of Long-Term Tinzaparin, a Low Molecular Weight Heparin (LMWH), Versus Warfarin for Treatment of Acute Venous Thromboembolism (VTE) in Cancer Patients - the CATCH Study
    Lee, Agnes Y. Y.
    Kamphuisen, Pieter W.
    Meyer, Guy
    Bauersachs, Rupert
    Janas, Mette S.
    Jarner, Mikala F.
    Khorana, Alok A.
    BLOOD, 2014, 124 (21)
  • [37] Long-term prospective study of recurrent venous thromboembolism in patients younger than 50 years
    García-Fuster, MJ
    Forner, MJ
    Fernández, C
    Gil, J
    Vaya, A
    Maldonado, L
    PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS, 2005, 34 (01) : 6 - 12
  • [38] Apixaban versus Warfarin for Treatment of Venous Thromboembolism in Patients Receiving Long-Term Dialysis
    Wetmore, James B.
    Herzog, Charles A.
    Yan, Heng
    Reyes, Jorge L.
    Weinhandl, Eric D.
    Roetker, Nicholas S.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 17 (05): : 693 - 702
  • [39] What is the long-term risk for new cancer in patients with a first episode of venous thromboembolism?
    Douketis, J.
    Gu, C.
    Piccioli, A.
    Ghirarduzzi, A.
    Pengo, V
    Prandoni, P.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 106 - 106
  • [40] The potential of target-specific oral anticoagulants for the acute and long-term treatment of venous thromboembolism
    Akwaa, Frank
    Spyropoulos, Alex C.
    CURRENT MEDICAL RESEARCH AND OPINION, 2014, 30 (11) : 2179 - 2190
12345